NFKB1 and neoplasm: One ongoing trial is evaluating markers more directly related to tumour cell activity: caspase-3 (a marker of apoptosis), hypoxia-inducible factor 1-alpha and NF-κB (transcription factors associated with cell proliferation) and VEGF (a pro-angiogenic growth factor).